A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource, 1 online resource.
- Language
-
Englisch
- Bibliographic citation
-
A phase I trial of the pan-ERBB inhibitor neratinib combined with the MEK inhibitor trametinib in patients with advanced cancer with EGFR mutation/amplification, HER2 mutation/amplification, HER3/4 mutation or KRAS mutation ; volume:92 ; number:2 ; day:14 ; month:6 ; year:2023 ; pages:107-118 ; date:8.2023
Cancer chemotherapy and pharmacology ; 92, Heft 2 (14.6.2023), 107-118, 8.2023
- Creator
-
Piha-Paul, Sarina A.
Tseng, Chieh
Tran, Hai T.
Gao, Meng
Karp, Daniel D.
Subbiah, Vivek
Tsimberidou, Apostolia M.
Kawedia, Jitesh D.
Fu, Siqing
Pant, Shubham
Yap, Timothy A.
Morris, Van K.
Kee, Bryan K.
Blum Murphy, Mariela
Lim, JoAnn
Meric-Bernstam, Funda
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s00280-023-04545-4
- URN
-
urn:nbn:de:101:1-2023101110113559883105
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:59 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Piha-Paul, Sarina A.
- Tseng, Chieh
- Tran, Hai T.
- Gao, Meng
- Karp, Daniel D.
- Subbiah, Vivek
- Tsimberidou, Apostolia M.
- Kawedia, Jitesh D.
- Fu, Siqing
- Pant, Shubham
- Yap, Timothy A.
- Morris, Van K.
- Kee, Bryan K.
- Blum Murphy, Mariela
- Lim, JoAnn
- Meric-Bernstam, Funda
- SpringerLink (Online service)
Other Objects (12)
Mutation testing with hyperproperties
Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome
Mutation
Mutation
Mutation
Mutation
Colorectal cancer with KRAS mutation
KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
Rapid screening of point mutations by mismatch amplification mutation assay PCR
Mutation, Somatic Mutation and Human Disease
Untersuchung möglicher Schnittstellen zur Erhebung von Informationen für das HyperBraille-Off-Screen-Model aus XUL-basierten Anwendungen
Kultur-Mutationen
Mutation testing with hyperproperties
Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome
Mutation
Mutation
Mutation
Mutation
Colorectal cancer with KRAS mutation
KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
Rapid screening of point mutations by mismatch amplification mutation assay PCR
Mutation, Somatic Mutation and Human Disease
Untersuchung möglicher Schnittstellen zur Erhebung von Informationen für das HyperBraille-Off-Screen-Model aus XUL-basierten Anwendungen
Kultur-Mutationen
Mutation testing with hyperproperties
Malignant gliomas with H3F3A G34R mutation or MYCN amplification in pediatric patients with Li Fraumeni syndrome
Mutation
Mutation
Mutation
Mutation
Colorectal cancer with KRAS mutation
KRAS mutation in relation to HER2 overexpression/amplification in colorectal cancer
Rapid screening of point mutations by mismatch amplification mutation assay PCR
Mutation, Somatic Mutation and Human Disease
Untersuchung möglicher Schnittstellen zur Erhebung von Informationen für das HyperBraille-Off-Screen-Model aus XUL-basierten Anwendungen